FCA Venture Partners is a venture capital and private equity firm investing in healthcare companies that is headquartered in Brentwood, Tennessee and was founded in 1996 and a subsidiary of Clayton Associates.
FCA Venture Partners typically invests between $3 to $6 million in healthcare information technology companies working to make the healthcare industry faster, cheaper, more efficient, and improve the quality of patient care. The firm looks to invest in companies that have achieved between $500,000 and $2 million of annual revenue with a product and established customer base.
Notable investments made by FCA Venture Partners include: Chartwise, Clinical Ink, Lumere, Provider Trust, StudioNow, One Medical Passport, Vericred, Health iPass, Identalsoft, Remedly, Vivante Health, Spiras health, and GoCheck.
FCA Venture Partners VI
On February 18, 2016 FCA Venture Partners announced raising $75 million for their FCA Venture Partners VI fund. The fund will focus on supporting early and growth-stage health information technology companies by making between 10-14 investments worth $3 to $6 million.
Vericred is a New York-based company founded by Dan Langevin.
A company offering a platform for access to bioresearch materials from institutions including antibodies and secondary detection reagents.
SafeRide Health is an Israel-based company.